EXCLI Journal Logo

EXCLI Journal publishes original research reports, authoritative reviews and case reports of experimental and clinical sciences.

EXCLI Journal (eISSN 1611-2156) is particularly keen to keep a broad view of science and technology, and therefore welcomes papers which bridge disciplines and may not suit the narrow specialism of other journals. Although the general emphasis is on biological sciences, studies from the following fields are explicitly encouraged:

Immunology, toxicology, ergonomics, neurosciences, psychology, occupational medicine, clinical and preclinical studies, drug development, pharmacology, environmental health, chemistry including analytical chemistry, biochemistry, cell biology, genetics, forensic medicine, oncology and cancer research, proteomics, systems biology, hepatology and gastroenterology, aging research, psychiatric research, behavioral sciences.

Graphical abstract


In order to provide our readers with a visual and thus faster and easier overview of the content of a publication, we expect a graphical summary (where possible) to be provided by the author from mid-2022.

However, we already encourage our authors to provide an additional graphical summary from now on.

Mandatory Metadata


Since June 2021, ORCID* is mandatory for all authors when submitting to EXCLI Journal. It is desirable that the ORCID contains the (current) institution as minimum information, so that each author can be clearly assigned via the ORCID in the metadata.

If ORCID, addresses or e-mail addresses are missing or incorrect, we reserve the right to reject such submissions due to formal errors.

*ORCID (Open Researcher and Contributor ID) should speed up the submission process. This unique identifier for authors is included as a mandatory field for all contributors in the submission tool.

Vol. 21 (2022)

Published continuously

Published: 2022-01-03

Tryptophan recovery index as a new biomarker for fitness

Authors: Alexander Pichler, Andreas Meinitzer, Dietmar Enko, Peter Schober, Georg Singer, Christoph Castellani, Markus Herrmann, Sandra J. Holasek, Holger Till, Jana Maria Windhaber
Pages: 888-896
Published: 2022-06-24
Issue: Vol. 21 (2022)

Transient receptor potential channel involvement in antinociceptive effect of citral in orofacial acute and chronic pain models

Authors: Sacha Aubrey Alves Rodrigues Santos, Marina de Barros Mamede Vidal Damasceno, Francisco Ernani Alves Magalhães, Barry John Sessle, Breytiner Amaro de Oliveira, Francisco Lucas Alves Batista, Antônio Eufrásio Vieira-Neto, Adriana Rolim Campos
Pages: 869-887
Published: 2022-06-24
Issue: Vol. 21 (2022)

Effects of curcumin on low-density lipoprotein oxidation

From experimental studies to clinical practice

Authors: Fatemeh Baratzadeh, Alexandra E. Butler, Prashant Kesharwani, Seyed Adel Moallem, Amirhossein Sahebkar
Pages: 840-851
Published: 2022-06-22
Issue: Vol. 21 (2022)

The association of ACE1, ACE2, TMPRSS2, IFITM3 and VDR polymorphisms with COVID-19 severity

A systematic review and meta-analysis

Authors: Zorana Dobrijević, Dragana Robajac, Nikola Gligorijević, Miloš Šunderić, Ana Penezić, Goran Miljuš, Olgica Nedić
Pages: 818-839
Published: 2022-06-20
Issue: Vol. 21 (2022)

Clinical presentation vs endoscopy for an early diagnosis of eosinophilic esophagitis

a case report

Authors: Michele Di Stefano, Giacomo Grandi, Vera Bonaso, Elisabetta Pagani, Gino Roberto Corazza, Antonio Di Sabatino
Pages: 651-655
Published: 2022-03-24
Issue: Vol. 21 (2022)

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders

a case report

Authors: Miriam Olivola, Vincenzo Arienti, Nicola Bassetti, Serena Civardi, Natascia Brondino
Pages: 540-543
Published: 2022-02-28
Issue: Vol. 21 (2022)

Current update on the protective effect of epicatechin in neurodegenerative diseases

Authors: Riya Thapa, Gaurav Gupta, Piyush Dave, Santosh Kumar Singh, Abhay Raizaday, Waleed Hassan Almalki, Govind Vyas, Sachin Kumar Singh, Kamal Dua, Yogendra Singh
Pages: 897-903
Published: 2022-06-24
Issue: Vol. 21 (2022)

Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1)

Authors: Akshansh Sharma, Rajiv Tonk, Ravi Shekhar, Sushil Dohare, Deepak Kumar
Pages: 904-905
Published: 2022-06-28
Issue: Vol. 21 (2022)
View all articles from this issue
View All Issues